Sign In
Buy ARPO
$13.14
-0.370 (-2.74%)
At Close: Aug 17, 2022
The Daily Biotech Pulse: PhaseBio To Start Potential Pivotal COVID-19 Trial, Immunomedics CEO Quits, Tetraphase Receives Sweetened Offer
12:00am, Thursday, 28'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 27)
ADC Therapeutics SA (NYSE:...
Aerpio Pharmaceuticals, Inc. (“Aerpio”) (ARPO) and Quantum Leap Healthcare Collaborative™ (Quantum Leap) announced today an agreement has been reached to evaluate razuprotafib in a new randomize
Is Aerpio Pharmaceuticals (ARPO) Outperforming Other Medical Stocks This Year?
03:30pm, Wednesday, 27'th May 2020
Is (ARPO) Outperforming Other Medical Stocks This Year?
New Strong Buy Stocks For May 26th
11:49am, Tuesday, 26'th May 2020
New Strong Buy Stocks For May 26th
Aerpio Pharmaceuticals, Inc. (ARPO) Upgraded to Strong Buy: Here's Why
04:00pm, Thursday, 21'st May 2020
Aerpio Pharmaceuticals, Inc. (ARPO) has been upgraded to a Zacks Rank 1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near
New Strong Buy Stocks For May 21st
12:01pm, Thursday, 21'st May 2020
New Strong Buy Stocks For May 21st
Placenta Growth Factor Pipeline Review, H1 2020: Companies Involved in Therapeutics Development - ResearchAndMarkets.com
12:00am, Thursday, 21'st May 2020
The
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
11:40am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 12) * Acceleron Pharma Inc (NASDAQ: XLRN)(reacted to its f
Gossamer Bio, Inc. (GOSS) CEO Sheila Gujrathi on Q1 2020 Results - Earnings Call Transcript
03:20am, Wednesday, 13'th May 2020
Gossamer Bio, Inc. (NASDAQ:GOSS) Q1 2020 Earnings Conference Call May 12, 2020 16:30 ET Company Participants Bryan Giraudo - Chief Financial Officer Sheila Gujr
The Daily Biotech Pulse: Gilead Signs Manufacturing Deal For Remdesivir, Bristol-Myers Gets Refuse-To-File Letter
12:00am, Wednesday, 13'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week Highs May 12)
Acceleron Pharma Inc (NASDAQ...
Aerpio Pharmaceuticals, Inc. (“Aerpio”) (ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat ocular diseases and diabetic complications, today announced
Gossamer Bio Announces First Quarter 2020 Financial Results and Provides Corporate Update
12:00am, Tuesday, 12'th May 2020
Gossamer Bio, Inc. (Nasdaq: GOSS), a clinical-stage biopharmaceutical company focused on discovering, acquiring, developing and commercializing therap
Aerpio Reports First Quarter 2020 Financial Results and Provides Business Update
12:00pm, Thursday, 07'th May 2020
CINCINNATI, May 07, 2020 -- Aerpio Pharmaceuticals, Inc. (“Aerpio”) (Nasdaq: ARPO), a biopharmaceutical company focused on developing compounds that activate Tie2 to treat.
Hypoxic Training Equipment Market Worth $230 Million by 2026: Next Generation Health and Fitness - ResearchAndMarkets.com
12:00am, Thursday, 07'th May 2020
The
Aerpio Pharmaceuticals, Inc. (ARPO) Gains As Market Dips: What You Should Know
09:45pm, Wednesday, 06'th May 2020
In the latest trading session, Aerpio Pharmaceuticals, Inc. (ARPO) closed at $0.63, marking a +1.69% move from the previous day.
